NUTEX HEALTH INC
NUTXNASDAQTrading Snapshot
- Day Range
- $208.58 – $211.15
- 52-Week Range
- $83.99 – $224.28
- Volume
- $1.74B
- Avg Volume
- $1.24B
- Shares Outstanding
- 6.9M
- Next Earnings
- Nov 28, 2026
Fundamentals Snapshot
- Annual Revenue
- $875M
- Last Q Revenue
- $211M
- P/E Ratio
- 8.1
- P/S Ratio
- 1.7x
- EPS (TTM)
- $26.19
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +40.7%
Why Investors Own NUTX
- ✓High-growth profile — revenue up +2.3% YoY with expanding US Equity exposure.
- ✓Healthy economics — 31% gross margin and 5% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
NUTEX HEALTH INC
NUTX
StockOtter · stockotter.spaceAbout NUTEX HEALTH INC
Nutex Health, Inc. functions as a technology-powered enterprise delivering healthcare services, structured into two key segments: its Hospital division and its Population Health Management division. The Hospital division is tasked with developing and overseeing various healthcare models, encompassing micro-hospitals, specialized medical centers, and hospital outpatient facilities. This segment currently owns and operates 21 locations spanning eight different states. Meanwhile, the Population Health Management division establishes and manages provider networks, such as independent physician associations. Additionally, its management services organizations furnish administrative, operational, and support assistance to its associated hospitals and physician groups. A proprietary, cloud-based technology platform within this division is crucial; it aggregates patient and provider data from multiple information systems, settings, and sources to construct a holistic view, thereby enabling more effective care delivery. The company maintains its corporate headquarters in Houston, Texas.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
Nutex Health: A High-Risk, High-Reward Play For Speculative Investors
Nutex Health has surged 134% since April, driven by its out-of-network micro-hospital model and expanding margins. It has staged a turnaround in 2026, driven by strong EPS growth after years of struggle. The company leve
Nutex Health: The Stock Has Had A Great Run, But New Guidance Justifies A Higher Target Price (Rating Upgrade)
Nutex Health is rated Strong Buy, with a new target price of $290.43, representing 39.1% upside from current levels. NUTX's profitability and growth metrics significantly outpace peers, driven by effective use of the No
Nutex Health Approved for Dual Listing on Nasdaq Texas
HOUSTON, Sept. 22, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX) today announced that it has received approval to dual-list its common stock on Nasdaq Texas.
Insider Selling: Nutex Health (NASDAQ:NUTX) Director Sells $43,492.75 in Stock
Nutex Health Inc. (NASDAQ: NUTX - Get Free Report) Director Scott Saunders sold 203 shares of the business's stock in a transaction dated Friday, September 18th. The stock was sold at an average price of $214.25, for a t
5 Stocks With Recent Price Strength Amid a Volatile September
EDRY, VNCE, NUTX, TXO and KB show strong recent price momentum despite a volatile September, backed by improving earnings expectations.
Nutex Health Inc. (NASDAQ:NUTX) Given Average Recommendation of “Buy” by Brokerages
Nutex Health Inc. (NASDAQ: NUTX - Get Free Report) has been given a consensus recommendation of "Buy" by the five research firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the sto